Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Thyroid Neoplasms × Thyroxine × Clear all

Phase

Status

Completed 3 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Postoperative Complications 1 Neoplasms 1 Hypothyroidism 1

Interventions

vandetanib 1 fosbretabulin 1 fludarabine 1 combretastatin 1 aldesleukin 1 Water 1 Thyroxine 1 Thyrotropin-Releasing Hormone 1 Tea 1 Paclitaxel 1 Milk 1 Iodine-124 1 Iodine-123 1 Fluorodeoxyglucose F18 1 Docetaxel 1 DNA 1 Cyclophosphamide 1 Coffee 1 Carboplatin 1 Biopsy, Fine-Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04868045 2023-02-21

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Withdrawn

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡